# Obatala Sciences, Inc.: Form D filings

Obatala Sciences, Inc., a biotechnology company in New Orleans, LA, filed 2 Form D notices with the SEC between 2020 and 2021. The latest, on January 15, 2021, reports $535,000 sold of a $1.5 million offering to 10 investors.

Find out what Obatala Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Obatala%20Sciences%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Obatala%20Sciences%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fobatala-sciences-inc-1828551)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Obatala%20Sciences%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Obatala%20Sciences%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fobatala-sciences-inc-1828551)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Louisiana](https://specstream.ai/data/form-d/state/louisiana): 144 rows, by operating companies, filed since November 1, 2024, $7.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/louisiana
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2000 LAKESHORE DRIVE, #4020, New Orleans, LA, 70148
- Phone: (504) 300-0266
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1828551

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 15, 2021 | Amendment | $1,500,000 | $535,000 | $965,000 | 10 | Sep 30, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1828551/000182855121000001/0001828551-21-000001-index.htm) |
| Oct 15, 2020 | New notice | $750,000 | $200,000 | $550,000 | 10 | Sep 30, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1828551/000182855120000001/0001828551-20-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jeffrey Gimble | Executive Officer, Director |  |
| Trivia Frazier | Executive Officer, Director |  |
| Xiying Wu Gimble | Executive Officer, Director |  |

## Other biotechnology companies in Louisiana that filed recently

- [28bio, Inc.](https://specstream.ai/data/form-d/company/28bio-inc-1769360) $8.5 million · Oct 29, 2026
- [Therapeutic Neuromodulation Systems LLC](https://specstream.ai/data/form-d/company/therapeutic-neuromodulation-systems-llc-2152054) $1.7 million · Sep 21, 2026

[Every Form D from the week of Jan 11, 2021](https://specstream.ai/data/form-d/week/2021-01-11) · [All recent filings in Louisiana](https://specstream.ai/data/form-d/state/louisiana) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Obatala Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).